Amgen Inc. v. Vidal (Fed. Cir. 2022) | McDonnell Boehnen Hulbert & Berghoff LLP

Earlier today, the Federal Circuit reversed the Final Written Decision, and reconsideration of that decision, by the U.S. Patent and Trademark Office Patent Trial and Appeal Board,...

Related Keywords

,Amgen ,Trademark Office Patent Trial ,Petitioners Apotex Inc ,Apotex Corp ,Federal Circuit ,Final Written Decision ,Appeal Board ,Petitioners Apotex ,Circuit Judges Chen ,Circuit Judge ,